Home Online Features Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA's SpeechDx Dataset, Gold-Standard Dataset for Alzheimer's Speech Biomarkers
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers
Hand-out
Press Releases
May 1, 2025

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers

By Alzheimer's Drug Discovery Foundation

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer's disease.

bradford

The Bradford Era

email
Local & Social